HOME >> MEDICINE >> NEWS
Drug treatment promising for halting Huntington's-related nerve death

DALLAS Jan. 31, 2005 Researchers at UT Southwestern Medical Center have discovered that drugs commonly used to treat psychiatric illnesses and blood disorders in humans may protect the brain cells that die in people with Huntington's disease, possibly delaying the onset and slowing the progression of the disease.

These findings, available online and in today's issue of Proceedings of the National Academy of Sciences, may offer new treatment options for Huntington's disease, which has no cure.

Huntington's disease is a neurological disorder in which the medium spiny striatal neurons, the nerve cells that control movement and certain mental functions die. Patients die within 10-15 years after onset of the disease.

The disease is caused by a mutation in the gene that makes the protein huntingtin. The mutation creates a long chain of the amino acid glutamine at one end of the protein. The length of the chain directly correlates with age of onset of the disease, with longer chains leading to symptoms earlier in life.

In previous studies, Dr. Ilya Bezprozvanny, associate professor of physiology at UT Southwestern, established that one of the defects that leads to death of nerve cells with the mutant huntingtin protein is improper regulation of calcium due to errant signals in the cells. Calcium is inappropriately released from its storage area in the cells, and eventually the cells die.

"We have developed a model that links the mutation in huntingtin with degeneration of motor neurons," Dr. Bezprozvanny said. "The model connects all the dots between the Huntington's disease mutation, defective calcium signaling in the cell, and subsequent degeneration of medium spiny striatal neurons."

In the current study, using the medium spiny neurons of mice that carry a copy of the mutated human huntingtin gene, Dr. Bezprozvanny and colleagues found that treatment of the cells in culture with the drug enoxaparin prevented inappropriate calciu
'"/>

Contact: Megha Satyanarayana
megha.saty@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
31-Jan-2005


Page: 1 2

Related medicine news :

1. Hormonal treatment improves survival in high-risk prostate cancer patients
2. Chronic pain treatments more effective when taken together, new study shows
3. Brain activity prior to treatment flags vulnerability to antidepressant side effects
4. Cultural and social factors influence prostate cancer treatment
5. Research offers hope of new treatments for liver damage
6. First mouse model for multiple system atrophy points to new treatment targets for brain diseases
7. Stanford patient is first to test new treatment for peripheral arterial disease
8. Scientist works on innovative treatments for brain tumors
9. Blacks less likely to get expensive, newer heart treatments
10. Growth hormone treatment improves symptoms of metabolic disorder in postmenopausal women
11. Study examines lessons learned at Africas first public antiretroviral treatment clinic

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/3/2020)... ... August 03, 2020 , ... ... of its newest product, CoverageCoach. The site provides a simple and efficient way ... products. The company sees CoverageCoach as an important expansion for the insurance marketing ...
(Date:7/31/2020)... ... July 31, 2020 , ... ... is announcing an expansion of clinical & technical capabilities to cover the full ... complete back and joint health solution. , Currently, employers interested in truly ...
(Date:7/22/2020)... ... July 22, 2020 , ... Ocean Tomo Transactions, LLC ... and manufacturing processes from Brock University for jurisdictions throughout North America, Europe and ... Brock University provides the manufacturing processes of novel opioid related compositions for pain ...
(Date:7/18/2020)... ... July 17, 2020 , ... “Frozen.” It’s not simply ... shoulder joint – oftentimes for unknown reasons – resulting in stiffness, persistent pain and ... an expert in treating problems of the upper limbs and joints and founder and ...
(Date:7/18/2020)... ... July 18, 2020 , ... When the federal government extended the Paycheck ... small and some bigger businesses to obtain a PPP loan. But the biggest obstacle ... Economy” do not realize they are eligible. , While 4.9 million companies obtained ...
Breaking Medicine News(10 mins):
(Date:8/3/2020)... ... August 03, 2020 , ... ... agreement has been reached, to amend and restate IDRI’s license with Immune Design, ... States and Canada). Under the amendment, the parties have agreed to modify the ...
(Date:7/31/2020)... Ariz. (PRWEB) , ... July 31, 2020 , ... ... received FDA clearance for reprocessing the St. Jude Medical BRK Transseptal Needle and ... transseptal needles is a milestone in single-use device reprocessing, as no other company ...
(Date:7/31/2020)... ... 31, 2020 , ... In an informal poll of 150 fans, conducted by ... refreshed Minnesota Twins “Minnie and Paul” logo that is more racially and culturally sensitive ... well before the civil rights movement in the United States. The Minnesota Twins have ...
Breaking Medicine Technology:
Cached News: